Back to today’s briefing

Story perspectives

AI in Pharma Soars: $1.8B to $13.1B by 2034

2/28/2025

40 6

Summary

Story summary

The global AI market in pharma and biotech is booming, currently valued at $1.8 billion and expected to soar to $13.1 billion by 2034, growing at an impressive 18.8% annually. North America leads the charge, with major companies pouring investments into cutting-edge technologies to revolutionize drug discovery and clinical trials, accelerating the path to life-saving treatments.

1 of 1

Story summary

The global AI market in pharma and biotech is booming, currently valued at $1.8 billion and expected to soar to $13.1 billion by 2034, growing at an impressive 18.8% annually. North America leads the charge, with major companies pouring investments into cutting-edge technologies to revolutionize drug discovery and clinical trials, accelerating the path to life-saving treatments.